CPRX

Catalyst Pharmaceuticals, Inc.

13.76 USD
+0.05 (+0.33%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Catalyst Pharmaceuticals, Inc. stock is down -7.87% since 30 days ago. The next earnings date is Feb 28, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 61.11% of the previous 17 February’s closed higher than January. In the last 1 Unusual Options Trades, there were 1 CALL.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
08 Jan 14:54 21 Jun, 2024 12.50 CALL 100 106

About Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals, Inc. focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS) and Ruzurgi.